Published in Biomaterials on July 23, 2007
Silk nanospheres and microspheres from silk/pva blend films for drug delivery. Biomaterials (2009) 1.59
Silk-based delivery systems of bioactive molecules. Adv Drug Deliv Rev (2010) 1.37
Tubular silk scaffolds for small diameter vascular grafts. Organogenesis (2011) 1.01
Spider silk constructs enhance axonal regeneration and remyelination in long nerve defects in sheep. PLoS One (2011) 1.00
Silk-based resorbable electronic devices for remotely controlled therapy and in vivo infection abatement. Proc Natl Acad Sci U S A (2014) 1.00
Review physical and chemical aspects of stabilization of compounds in silk. Biopolymers (2012) 0.98
Silk-based biomaterials for sustained drug delivery. J Control Release (2014) 0.94
Mechanisms of controlled release from silk fibroin films. Biomacromolecules (2011) 0.91
A review of bioactive release from nerve conduits as a neurotherapeutic strategy for neuronal growth in peripheral nerve injury. Biomed Res Int (2014) 0.89
Complementary effects of two growth factors in multifunctionalized silk nanofibers for nerve reconstruction. PLoS One (2014) 0.88
Chitosan conduits combined with nerve growth factor microspheres repair facial nerve defects. Neural Regen Res (2013) 0.87
Use new PLGL-RGD-NGF nerve conduits for promoting peripheral nerve regeneration. Biomed Eng Online (2012) 0.85
Silk constructs for delivery of musculoskeletal therapeutics. Adv Drug Deliv Rev (2012) 0.84
Neural responses to electrical stimulation on patterned silk films. J Biomed Mater Res A (2013) 0.84
A mild process to design silk scaffolds with reduced β-sheet structure and various topographies at the nanometer scale. Acta Biomater (2014) 0.83
Coseeded Schwann cells myelinate neurites from differentiated neural stem cells in neurotrophin-3-loaded PLGA carriers. Int J Nanomedicine (2012) 0.81
The effects of controlled release of neurotrophin-3 from PCLA scaffolds on the survival and neuronal differentiation of transplanted neural stem cells in a rat spinal cord injury model. PLoS One (2014) 0.79
In vivo study of ethyl-2-cyanoacrylate applied in direct contact with nerves regenerating in a novel nerve-guide. J Mater Sci Mater Med (2010) 0.78
Incorporation of chitosan microspheres into collagen-chitosan scaffolds for the controlled release of nerve growth factor. PLoS One (2014) 0.78
Controlled release of stromal cell-derived factor-1α from silk fibroin-coated coils accelerates intra-aneurysmal organization and occlusion of neck remnant by recruiting endothelial progenitor cells. Int J Clin Exp Pathol (2014) 0.77
Biopolymers and supramolecular polymers as biomaterials for biomedical applications. MRS Bull (2015) 0.77
Promotion of peripheral nerve regeneration of a peptide compound hydrogel scaffold. Int J Nanomedicine (2013) 0.77
A comparison of the performance of mono- and bi-component electrospun conduits in a rat sciatic model. Biomaterials (2014) 0.76
Microencapsulation by solvent extraction/evaporation: reviewing the state of the art of microsphere preparation process technology. J Control Release (2005) 2.17
Silk microspheres for encapsulation and controlled release. J Control Release (2006) 1.81
Growth factor gradients via microsphere delivery in biopolymer scaffolds for osteochondral tissue engineering. J Control Release (2008) 1.72
Porous silk fibroin 3-D scaffolds for delivery of bone morphogenetic protein-2 in vitro and in vivo. J Biomed Mater Res A (2006) 1.68
Bone morphogenetic protein-2 decorated silk fibroin films induce osteogenic differentiation of human bone marrow stromal cells. J Biomed Mater Res A (2004) 1.59
Control of in vitro tissue-engineered bone-like structures using human mesenchymal stem cells and porous silk scaffolds. Biomaterials (2006) 1.56
Cartilage-like tissue engineering using silk scaffolds and mesenchymal stem cells. Tissue Eng (2006) 1.45
Silk fibroin as a vehicle for drug delivery applications. J Control Release (2010) 1.40
Silk fibroin spheres as a platform for controlled drug delivery. J Control Release (2008) 1.35
Localized delivery of growth factors for bone repair. Eur J Pharm Biopharm (2004) 1.30
Nerve conduits and growth factor delivery in peripheral nerve repair. J Peripher Nerv Syst (2007) 1.29
Effect of scaffold design on bone morphology in vitro. Tissue Eng (2006) 1.28
TLR ligands and antigen need to be coencapsulated into the same biodegradable microsphere for the generation of potent cytotoxic T lymphocyte responses. Vaccine (2008) 1.26
Nondestructive micro-computed tomography for biological imaging and quantification of scaffold-bone interaction in vivo. Biomaterials (2007) 1.24
PEGylation as a tool for the biomedical engineering of surface modified microparticles. J Pharm Sci (2008) 1.23
Osteogenesis by human mesenchymal stem cells cultured on silk biomaterials: comparison of adenovirus mediated gene transfer and protein delivery of BMP-2. Biomaterials (2006) 1.22
Formulation aspects of biodegradable polymeric microspheres for antigen delivery. Adv Drug Deliv Rev (2005) 1.22
Administration routes affect the quality of immune responses: A cross-sectional evaluation of particulate antigen-delivery systems. J Control Release (2010) 1.20
On the biomedical promise of cell penetrating peptides: limits versus prospects. J Pharm Sci (2008) 1.18
Encapsulation of peptides in biodegradable microspheres prolongs their MHC class-I presentation by dendritic cells and macrophages in vitro. Vaccine (2003) 1.14
Insulin-like growth factor I releasing silk fibroin scaffolds induce chondrogenic differentiation of human mesenchymal stem cells. J Control Release (2007) 1.12
Transfer of lipophilic markers from PLGA and polystyrene nanoparticles to caco-2 monolayers mimics particle uptake. Pharm Res (2002) 1.12
Localized insulin-like growth factor I delivery to enhance new bone formation. Bone (2003) 1.12
Particulate vaccines: on the quest for optimal delivery and immune response. Drug Discov Today (2011) 1.10
Chances and pitfalls of cell penetrating peptides for cellular drug delivery. Eur J Pharm Biopharm (2004) 1.09
Transport of surface-modified nanoparticles through cell monolayers. Chembiochem (2005) 1.08
Decoding the entry of two novel cell-penetrating peptides in HeLa cells: lipid raft-mediated endocytosis and endosomal escape. Biochemistry (2005) 1.08
Schwann cell delivery of neurotrophic factors for peripheral nerve regeneration. J Peripher Nerv Syst (2010) 1.07
Silk coatings on PLGA and alginate microspheres for protein delivery. Biomaterials (2007) 1.06
Synergistic effect of GDNF and NGF on axonal branching and elongation in vitro. Neurosci Res (2009) 1.05
Encapsulation of proteins and peptides into biodegradable poly(D,L-lactide-co-glycolide) microspheres prolongs and enhances antigen presentation by human dendritic cells. Vaccine (2005) 1.05
Phagocytosis and phagosomal fate of surface-modified microparticles in dendritic cells and macrophages. Pharm Res (2003) 1.03
Optimization strategies for electrospun silk fibroin tissue engineering scaffolds. Biomaterials (2009) 1.03
Particulate formulations for the delivery of poly(I:C) as vaccine adjuvant. Adv Drug Deliv Rev (2013) 1.02
In vitro phagocytosis and monocyte-macrophage activation with poly(lactide) and poly(lactide-co-glycolide) microspheres. Eur J Pharm Sci (2002) 1.01
Effects of chondrogenic and osteogenic regulatory factors on composite constructs grown using human mesenchymal stem cells, silk scaffolds and bioreactors. J R Soc Interface (2008) 1.01
Growth factor delivery systems and repair strategies for damaged peripheral nerves. J Control Release (2011) 0.99
Collagen nerve conduits releasing the neurotrophic factors GDNF and NGF. J Control Release (2009) 0.98
Metabolic cleavage of cell-penetrating peptides in contact with epithelial models: human calcitonin (hCT)-derived peptides, Tat(47-57) and penetratin(43-58). Biochem J (2004) 0.98
Microporous silk fibroin scaffolds embedding PLGA microparticles for controlled growth factor delivery in tissue engineering. Biomaterials (2009) 0.98
Lympho-geographical concepts in vaccine delivery. J Control Release (2010) 0.97
Ligand-specific targeting of microspheres to phagocytes by surface modification with poly(L-lysine)-grafted poly(ethylene glycol) conjugate. Pharm Res (2003) 0.97
Concomitant delivery of a CTL-restricted peptide antigen and CpG ODN by PLGA microparticles induces cellular immune response. J Drug Target (2009) 0.97
Evaluation of pH-dependent membrane-disruptive properties of poly(acrylic acid) derived polymers. Eur J Pharm Biopharm (2003) 0.97
Amphiphilic dendrimers: novel self-assembling vectors for efficient gene delivery. Angew Chem Int Ed Engl (2003) 0.96
Differentiation restricted endocytosis of cell penetrating peptides in MDCK cells corresponds with activities of Rho-GTPases. Pharm Res (2007) 0.95
Silk fibroin/hyaluronan scaffolds for human mesenchymal stem cell culture in tissue engineering. Biomaterials (2009) 0.95
Electrospun matrices for localized drug delivery: current technologies and selected biomedical applications. Eur J Pharm Biopharm (2012) 0.94
DNA-loaded biodegradable microparticles as vaccine delivery systems and their interaction with dendritic cells. Adv Drug Deliv Rev (2005) 0.94
The cell penetrating peptides pVEC and W2-pVEC induce transformation of gel phase domains in phospholipid bilayers without affecting their integrity. Biochemistry (2006) 0.94
Cotton wool-like nanocomposite biomaterials prepared by electrospinning: in vitro bioactivity and osteogenic differentiation of human mesenchymal stem cells. J Biomed Mater Res B Appl Biomater (2008) 0.93
Gentamicin-loaded microspheres for treatment of experimental Brucella abortus infection in mice. J Antimicrob Chemother (2005) 0.92
Non-invasive time-lapsed monitoring and quantification of engineered bone-like tissue. Ann Biomed Eng (2007) 0.91
The support of adenosine release from adenosine kinase deficient ES cells by silk substrates. Biomaterials (2006) 0.90
Biophysical properties of chitosan/siRNA polyplexes: profiling the polymer/siRNA interactions and bioactivity. J Control Release (2011) 0.90
Microparticle-mediated transfection of non-phagocytic cells in vitro. J Drug Target (2002) 0.90
Delivery of tumor antigens to dendritic cells using biodegradable microspheres. Methods Mol Med (2005) 0.89
Miconazole nanosuspensions: Influence of formulation variables on particle size reduction and physical stability. Int J Pharm (2010) 0.89
Phenotype and functional analysis of human monocyte-derived dendritic cells loaded with biodegradable poly(lactide-co-glycolide) microspheres for immunotherapy. J Immunol Methods (2004) 0.88
The use of sulfonated silk fibroin derivatives to control binding, delivery and potency of FGF-2 in tissue regeneration. Biomaterials (2009) 0.88
Gentamicin-loaded microspheres for reducing the intracellular Brucella abortus load in infected monocytes. J Antimicrob Chemother (2004) 0.88
Effect of controlled co-delivery of synergistic neurotrophic factors on early nerve regeneration in rats. Biomaterials (2010) 0.87
Biopolymer-based growth factor delivery for tissue repair: from natural concepts to engineered systems. Tissue Eng Part B Rev (2009) 0.87
Remodeling of tissue-engineered bone structures in vivo. Eur J Pharm Biopharm (2013) 0.87
Surface coating of PLGA microparticles with protamine enhances their immunological performance through facilitated phagocytosis. J Control Release (2008) 0.86
Controlled nerve growth factor release from multi-ply alginate/chitosan-based nerve conduits. Eur J Pharm Biopharm (2008) 0.86
Mannose-based molecular patterns on stealth microspheres for receptor-specific targeting of human antigen-presenting cells. Langmuir (2008) 0.86
Metabolic cleavage and translocation efficiency of selected cell penetrating peptides: a comparative study with epithelial cell cultures. AAPS J (2008) 0.86
Ultrasonic atomisation into reduced pressure atmosphere--envisaging aseptic spray-drying for microencapsulation. J Control Release (2004) 0.86
Improved stimulation of human dendritic cells by receptor engagement with surface-modified microparticles. J Drug Target (2003) 0.85
The preservation of phenotype and functionality of dendritic cells upon phagocytosis of polyelectrolyte-coated PLGA microparticles. Biomaterials (2006) 0.85